{"id":"880","presentation":"P-10.3.2 - Lorecivivint (SM04690): An Intra-articular Wnt Pathway Inhibitor for Knee Osteoarthritis Treatment - Phase 2b Patient-Reported Outcomes","session":"0.0 - Poster Viewing \/ Coffee Break \/ Exhibition","filename":"Tambiah 10.3.2.pptx","speaker":"S. Kennedy<small> (San Diego, US)<\/small>","photo":"","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/icrs2019\/880\/jpg\/tambiah10.3.2\/thumbnails\/0.png","html5":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/icrs2019\/880\/html\/tambiah10.3.2\/data\/","what":"html5","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]